| Financial Year |
March 31 2023 |
| Monetary Funds |
874,105,668.79 |
| Held-for-trading Financial Assets |
80,000.00 |
| Notes Receivable |
65,235.90 |
| Accounts Receivable |
439,210,649.48 |
| Advances to Suppliers |
39,900,770.49 |
| Other Receivables |
16,685,984.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
625,247,605.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
121,391,095.81 |
| Other Current Assets |
25,819,775.75 |
| Total Current Assets |
2,182,891,058.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,567,653.33 |
| Long-term Equity Investment |
-- |
| Investment Properties |
84,131,718.75 |
| Fixed Assetes |
311,913,123.95 |
| Under-construction Projects |
246,492,851.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,302,266.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,388,263.46 |
| Deferred Income Tax Assets |
56,630,741.45 |
| Other Non-Current Assets |
52,059,317.37 |
| Sub-Total of Non-Current Assets |
937,451,691.53 |
| Total Assets |
3,120,342,750.40 |
| Short-Term Loans |
5,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
621,225,776.04 |
| Accounts Payable |
609,576,156.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
97,661,414.58 |
| Taxes Payable |
13,479,537.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,158,332.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,878,059.59 |
| Other Current Liabilities |
12,301,754.91 |
| Sub-Total of Current Liabilities |
1,779,646,448.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
50,559,915.15 |
| Deferred Income Tax Liabilities |
4,352,752.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,509,301.51 |
| Total Liabilities |
1,856,155,750.30 |
| Paid-In Capital(Or Share Stock) |
359,994,173.00 |
| Capital Surplus |
288,540,108.96 |
| Surplus Reserve |
121,420,674.06 |
| LESS:Treasury Stock |
13,439,530.69 |
| Undistributed Profits |
511,708,217.21 |
| Minority Stockholder's Interest |
1,957,622.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,262,229,377.89 |
| Owner's Equity（Stockholder's Equity） |
1,264,187,000.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,120,342,750.40 |
